PDA/ANSI Standard 06-2025 Released to Provide Framework for Assessing Quality Culture

The recently published PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools has drawn attention from industry experts. Matt Cushing, Vice President of Quality and Science at Nelson Labs, and Susan J. Schniepp, a distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company, have provided insights into the standard’s significance. Released in February 2025, the document aims to offer structured guidance for assessing quality culture within organizations.

Cushing and Schniepp discussed the framework outlined in the standard, which includes various models and tools designed to evaluate and enhance quality culture practices. The publication emphasizes the importance of fostering a robust quality culture as part of regulatory compliance and operational excellence. Their analysis highlights how this guidance can assist organizations in identifying gaps in their current practices while providing actionable steps for improvement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 3, 2025

Related posts:

Biosimilars Market to Reach $75 Billion by 2025, Analysis Shows Drug Patent Watch Guide Highlights ICH Guidelines and Analytical Methods for Generic Drug Stability Testing. PD-1 and VEGF Bispecific Antibodies Highlighted at 2025 ASCO Meeting Amid Discussions on Oral SERDs and GLP-1 Agonists in Oncology Scott Tillman Discusses Transition to Cloud-Based Systems to Address Legacy Challenges in Pharma Industry

Author

Mark Chiang